| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $5.76M | $10.82M | $10.52M | $13.16M | $11.50M |
| R&D | $1.85M | $3.19M | $5.00M | $6.55M | $5.48M |
| SG&A | $3.72M | $7.06M | $4.70M | $5.17M | $4.94M |
| Operating Income | -$5.76M | -$10.82M | -$10.52M | -$13.16M | -$11.50M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.03M | -$11.51M | -$10.06M | -$13.18M | -$11.23M |
| EPS (basic) | -8.9300 | -56.9400 | – | -4.5600 | -0.2800 |
| EPS (diluted) | -8.9300 | -56.9400 | -2766.8500 | – | – |
| Shares (diluted) | $787.02K | $202.11K | $3.64K | – | – |